Lawson invests over $200,000 in local covid research         

Hospital-based research is uniquely positioned to tackle the unprecedented COVID-19 challenge and quickly translate results into illness prevention and care for patients. Lawson Health Research Institute, the research institute of London Health Sciences Centre (LHSC) and St. Joseph’s Health Care London, has awarded more than $202,000 to its research teams to support critical discoveries during the pandemic. 

Man cooking and smelling food

In the new study, patients with loss of smell will answer questions through a publicly accessible survey. 

As part of an initiative called the Global Consortium for Chemosensory Research (GCCR), scientists at Lawson Health Research Institute and Western University are studying the sudden loss of smell in COVID-19 patients. They are asking individuals with confirmed or presumptive cases of COVID-19 worldwide to participate in a survey to better understand this symptom.

Jaryd Christie

Lawson researchers are developing a new software that uses artificial intelligence (AI) to identify which patients are likely to have recurring cancer.

Lung cancer is the most commonly diagnosed cancer in Canada. While the standard treatment for patients with early-stage lung cancer is surgery, up to half of these patients may develop a recurrence after their treatment. 

Jaryd Christie is a Master’s candidate working with Lawson Scientist, Dr. Sarah Mattonen. Together, they are working to develop a new software that uses artificial intelligence (AI) to identify which patients are likely to have recurring cancer. 

Pages